Somatostatin-receptor scintigraphy methods-indications-results;Somatostatinrezeptorszintigraphie: Methodik, Indikationen, Ergebnisse

Radiologe

Volumn 36, Issue 1, 1996, Pages 81-88

  Eising, E G ^a   Bier, D ^a   Knust, E J ^a   Reiners, C ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Indications; Methods; Results; Somatostatinrezeptorszintigraphy

Indexed keywords

DIAGNOSTIC AGENT; OCTREOTIDE; SOMATOSTATIN RECEPTOR; IODINE 123; PENTETREOTIDE; PENTETREOTIDE IN 111;

CARCINOID; COMPUTER ASSISTED DIAGNOSIS; ECTOPIC HORMONE PRODUCTION; GASTROINTESTINAL TUMOR; HUMAN; MEDULLARY CARCINOMA; NEOPLASM; REVIEW; SCINTISCANNING; THYROID TUMOR; ARTICLE; CLINICAL TRIAL; DIGESTIVE SYSTEM CANCER; RADIATION EXPOSURE;

CARCINOID TUMOR; CARCINOMA, MEDULLARY; GASTROINTESTINAL NEOPLASMS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; NEOPLASMS; OCTREOTIDE; PARANEOPLASTIC ENDOCRINE SYNDROMES; RECEPTORS, SOMATOSTATIN; THYROID NEOPLASMS;

EID: 0029662150     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001170050043     Document Type: Article

References (33)

1. Amartey JK (1993) Technetium-99m labeled somatostatin and analogs: synthesis, characterization and in vivo evaluation. Nucl Med Biol 20: 539-543
2. Bach D, Adrian HJ, Eisenhut M, Dörr U, Bihl H (1993) Biodistribution und Pharmakokinetik radiomarkierter Somatostatin-Analoga. Nukiearmediziner 4: 269-280
3. 1]-octreotide. a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci 49: 1583-1591
4. Bares R, Galonska P, Dempke W, Handt S, Büll U, Osieka R (1993) Somatostatin receptor scintigraphy in malignant lymphorna: first results and comparison with glucose metabolism measured by positron-emission tomography. Horm Metab Res [Suppl] 27: 56-58
5. Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J (1992) SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31: 1133-1140
6. Bomanji J, Ur S, Mather S, Moyes J, Ellison D, Grossman A, Britton KE, Besser GM (1992) A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors. J Nucl Med 33: 1121-1124
7. 2]-somatostatin analogs: prolonged inhibition of growth hormone secretion. Biochem Biophys Res Comm 60: 1202-1207
8. 3]octreotide. Eur J Nucl Med 20: 1089-1094
9. Dörr U, Frank-Raue K, Raue F, Sautter-Bihl ML, Guzman G, Buhr HJ, Bihl H (1993) The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinoma. Nucl Med Commun 14: 439-445
10. Dörr U, Rath U, Sautter-Bihl ML, Guzman G, Bach D, Adrian J, Bihl H (1993) Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue. Eur J Nucl Med 20: 431-433
11. Dörr U, Sautter-Bihl ML, Benz P, Meinke J, Schilling FH, Koscielniak E, Treuner J, Holle Y, Bihl H (1993) Beitrag der Somatostatin-Rezeptor-Szintigraphie zur In-vivo-Diagnostik von Neuroblastomen. Nuklearmediziner 5: 341-348
12. Dörr U, Wurstlin S, Frank-Raue K, Hehrmann R, Iser G, Scholz M, Guhl L, Buhr HJ, Bihl H (1993) Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative study. Horm Metab Res [Suppl] 27: 48-55
13. 1]-Oktreotid (Octreoscan®) bei medullären Schilddrüsenkarzinomen, GEP-Tumoren und Karzmoiden. Nuklearmedizin 34: 1-7
14. Flamen P, Bossuyt A, De Greve J, Pipeleers-Marichal M, Keuppens F, Somers G (1993) Imaging of renal cell cancer with radiolabelled octreotide. Nucl Med Commun 14: 873-877
15. 111In-Octreotid bei Patientinnen mit palpablen Mammatumoren. Nuklearmediziner 5: 325-330
16. Höring E (1993) Symptomatik. Diagnostik und Therapie endokriner Tumoren des Pankreas und Gastrointestinaltraktes. Nuklearmediziner 4: 257-268
17. 111In-pentetreotide for endocrine gastroenteropancreatic tumors. Horm Metab Res [Suppl] 27: 28-35
18. Kebabian JW, Neumeyer JL (1994) The RBI Handbook of Receptor Classification. Research Biochemicals International, Natick
19. Krausz Y, Ish-Shalom S, Dejong RBJ, Shibley N, Lapidot M, Maaravi Y, Glaser B (1994) Somatostatin-Receptor imaging of medullary thyroid carcinoma. Clin Nucl Med 19: 416-421
20. Krenning EP, Bakker WH, Kooij PPM, Breeman WAP, Oei HY, de Jong M, Reubi JC, Visser TJ, Bruns C, Kwekkeboom DJ, Reijs AEM, van Hagen PM, Koper JW, Lamberts SWJ (1992) Somatostatin receptor scintigraphy with Indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med 33: 652-658
21. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20: 716-731
22. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PPM, Lamberts SWJ (1993) Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 20: 283-292
23. Kwekkeboom DJ, van Urk H, Pauw BHK, Lamberts SWJ, Kooij PPM, Hoogma PLM, Krenning EP (1993) Octreotide scintigraphy for the detection of paragangliomas. J Nucl Med 34: 873-878
24. Maina Th, Stolz B, Albert R, Bruns Chr, Koch P, Macke H (1994) Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technetium-99 m. Eur J Nucl Med 21: 437-444
25. 111In-DTPA-octreotide: a preliminary study. Nucl Med Commun 14: 962-968
26. Pless J (1990) Chemie und Pharmakologie von Sandostatin. Z Gastroenterol [Suppl 2] 28: 4-7
27. Reiners Chr (1991) Nuklearmedizinische Diagnostik des medullären Schilddrüsenkarzinoms und des Sipple-Syndroms. Medwelt 42: 1001-1006
28. Reubi JC (1985) New specific radioligand for the subpopulation of brain somatostatin receptors. Life Sci 36: 1829-1836
29. Scheidhauer K, Hildebrandt G, Luyken C, Schomacker K, Klug N, Schicha H (1993) Somatostatin receptor scintigraphy in brain tumors and pituary tumors: first experiences. Horm Metab Res [Suppl] 27: 59-62
30. Scherübl, H, Bader M, Fett U, Hamm B, Schmidt-Gayk H, Koppenhagen K, Dop FJ, Riecken EO, Wiedenmann B (1993) Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology 105: 1705-1709
31. Smith-Jones PM, Stolz B, Bruns Chr, Albert R, Reist HW, Fridrich R, Macke HR (1993) Gallium-67/Gallium-68-[DFO]-octreotide - a potential radio-pharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies. J Nucl Med 35: 317-325
32. Wurm K, Dörr U, Sautter-Bihl ML, Meinke J, Höring E, Räth U, Bihl H (1993) Indikationen zur Somatostatin-Rezeptor-Szintigraphie bei Karzinoiden. Nuklearmediziner 4: 293-308
33. Yeaton P, Frieson HF (1993) Octreotide reduces enteral protein losses in ménétrier's disease. A J Gastroenterol 88: 95-98